Concepedia

Kathy Guo

KG

Statistics

Publications

11

Citations

3.2K

H-Index

10

Active since

2012

Affiliations

University of Birmingham(Current)

NIHR Birmingham Liver Biomedical Research Unit

Cancer Research UK Clinical Trials Unit

National Institute for Health and Care Research

Queen Elizabeth Hospital Birmingham

Kathy Guo is an author at University of Birmingham specializing in liver disease, pharmacology, and life sciences.

Publications per year

2012–2025

11

Publications

11

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

Matthew J. Armstrong, Piers Gaunt, Guruprasad P. Aithal et al. · The Lancet · 2015 · 2.1K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +5

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis

Matthew J. Armstrong, Diana Hull, Kathy Guo et al. · Journal of Hepatology · 2015 · 447 citations · Full text

Medicine, Endocrinology, Pharmacology +15

FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a hepatic stellate cell senescence secretome

Fuming Li, Peiwei Huangyang, Michelle Burrows et al. · Nature Cell Biology · 2020 · 204 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial

Philip N. Newsome, Richard Fox, Andrew King et al. · The Lancet. Gastroenterology & hepatology · 2017 · 159 citations · Full text

Medicine, Hematology, Immunology +16

Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis

Ye Htun Oo, Susan Ackrill, Richard Cole et al. · JHEP Reports · 2019 · 79 citations · Full text

Life Sciences, Immunology, Good Manufacturing Practice +16

1–5 of 11